ALTX THERAPEUTICS LIMITED

Active Huntingdon

Research and experimental development on biotechnology

Research and experimental development on biotechnology
A

ALTX THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 28 Aug 2025 Active Huntingdon, England website.com
Research and experimental development on biotechnology

Previous Company Names

SLINGSHOT ALTCO LIMITED 28 Aug 2025 — 19 Nov 2025
Accounts Due 31 Dec 2026 8 months remaining
Confirmation
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

Burnham House, Splash Lane Wyton Huntingdon PE28 2AF England

Full company profile for ALTX THERAPEUTICS LIMITED (16677457), an active company based in Huntingdon, England. Incorporated 28 Aug 2025. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Awaiting first accounts
For period ending 31 March 2026
Due by 31 December 2026 8 months remaining

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 6,918,000 Shares £4.52m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
4 Nov 20254,518,000£4.52m£1
20 Oct 20252,400,000£24£0

Officers

Officers

3 active
Status
Allen, David George, DrDirectorBritishUnited Kingdom664 Nov 2025Active
Archangel Accounting LimitedCorporate-secretaryUnknownUnknown20 Oct 2025Active
Hodgkin, Edward EliotDirectorBritishUnited Kingdom6228 Aug 2025Active

Shareholders

Shareholders (1)

Slingshot Therapeutics Holdings Limited
100.0%
1

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Slingshot Therapeutics Holdings Limited

Unknown

Active
Notified 4 Nov 2025
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent
  • Right To Appoint And Remove Directors

Slingshot Therapeutics Holdings Limited

Ceased 20 Oct 2025

Ceased

Dr Simon Boulton

Ceased 4 Nov 2025

Ceased

Group Structure

Group Structure

ALTX THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Nov 2025Persons With Significant ControlCessation of Simon Boulton as a person with significant control on 4 Nov 2025
27 Nov 2025OfficersAppointment of Dr Simon Joseph Boulton as director on 4 Nov 2025
25 Nov 2025ResolutionResolutions
25 Nov 2025OfficersAppointment of Dr David George Allen as director on 4 Nov 2025
25 Nov 2025Persons With Significant ControlSlingshot Therapeutics Holdings Limited notified as a person with significant control
27 Nov 2025 Persons With Significant Control

Cessation of Simon Boulton as a person with significant control on 4 Nov 2025

27 Nov 2025 Officers

Appointment of Dr Simon Joseph Boulton as director on 4 Nov 2025

25 Nov 2025 Resolution

Resolutions

25 Nov 2025 Officers

Appointment of Dr David George Allen as director on 4 Nov 2025

25 Nov 2025 Persons With Significant Control

Slingshot Therapeutics Holdings Limited notified as a person with significant control

Recent Activity

Latest Activity

Cessation of Simon Boulton as a person with significant control on 4 Nov 2025

5 months ago on 27 Nov 2025

Appointment of Dr Simon Joseph Boulton as director on 4 Nov 2025

5 months ago on 27 Nov 2025

Resolutions

5 months ago on 25 Nov 2025

Appointment of Dr David George Allen as director on 4 Nov 2025

5 months ago on 25 Nov 2025

Slingshot Therapeutics Holdings Limited notified as a person with significant control

5 months ago on 25 Nov 2025